ArticlePharmacoEconomics1999
Costs of diabetes. A methodological analysis of the literature.
Article in PharmacoEconomics, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 4 syntheses or guidelines pooled it.
- The costs of diabetes treatment in low- and middle-income countries: a systematic review.BMJ global health · 2019Pooled it
- Systematic review of economic burden of heart failure.Heart failure reviews · 2018Pooled it
- Cost-of-illness studies for bipolar disorder: systematic review of international studies.PharmacoEconomics · 2015Pooled it
- Usefulness of US cost-of-illness studies in healthcare decision making.PharmacoEconomics · 2001Pooled it
- Biphasic insulin Aspart 30 vs. NPH plus regular human insulin in type 2 diabetes patients; a cost-effectiveness study.BMC endocrine disorders · 2016Trial
- Methods for Estimating Avoidable Costs of Excessive Alcohol Consumption.International journal of environmental research and public health · 2021Article
- Prevalence and socioeconomic burden of diabetes mellitus in South Korean adults: a population-based study using administrative data.BMC public health · 2021Article
- Methodological considerations in the assessment of direct and indirect costs of back pain: A systematic scoping review.PloS one · 2021Article
- Economic menace of diabetes in India: a systematic review.International journal of diabetes in developing countries · 2020Review
- Disease and Economic Burden of Hospitalizations Attributable to Diabetes Mellitus and Its Complications: A Nationwide Study in Brazil.International journal of environmental research and public health · 2018Article
- Cost of diabetic eye, renal and foot complications: a methodological review.The European journal of health economics : HEPAC : health economics in prevention and care · 2017Review
- Dutch guidelines for economic evaluation: 'from good to better' in theory but further away from pharmaceuticals in practice?Journal of the Royal Society of Medicine · 2017Article
- Cost-of-illness studies: concepts, scopes, and methods.Clinical and molecular hepatology · 2014Review
- Direct cost for initial management of prostate cancer: a systematic review.Current oncology (Toronto, Ont.) · 2013Article
- The cost of Type 1 diabetes mellitus in the United Kingdom: a review of cost-of-illness studies.The European journal of health economics : HEPAC : health economics in prevention and care · 2013Article
- Cost-of-illness studies: a guide to critical evaluation.PharmacoEconomics · 2011Article
- Treatment cost for typhoid fever at two hospitals in Kolkata, India.Journal of health, population, and nutrition · 2009Article
- Cost of severe hypoglycaemia in patients with type 1 diabetes in Spain and the cost-effectiveness of insulin lispro compared with regular human insulin in preventing severe hypoglycaemia.International journal of clinical practice · 2008Article
- Direct medical costs unequivocally related to diabetes in Italian specialized centers.The European journal of health economics : HEPAC : health economics in prevention and care · 2004Article
- Cost-of-illness studies in diabetes mellitus.PharmacoEconomics · 2004Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo review studies on the costs of diabetes and its complications through a scheme designed specifically for assessing the quality of cost-of-illness (COI) studies. DESIGN AND
settingThe methodology of COI studies in diabetes was analysed in order to assess the significance of quantitative results. The scheme adopted 7 items identified as the main points for discussing the methodological choices governing the results. We also used a checklist based on questions related to the 7 items. MAIN OUTCOME MEASURES AND
resultsThe answers showed that many studies appear not to give technical details, so it is hard to understand the method. Methodological choices varied widely between the studies. This is probably due to the lack of consensus on the methodology of COI studies. Based on the findings of this review, we suggest also some specific points that could help produce more reliable results on the costs of diabetes.
conclusionsClearly, a general consensus on COI studies is still remote, making the value of any comparison of results questionable.
Indexed as
Identifiers
10538331What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.